4
Changes in Ownership
ADARx Pharmaceuticals, Inc. Filed Acc 0001729510-26-000006
Options or other derivatives
- President and CEO acquired 1,024,152 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Li Zhen · President and CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-24 | Grant or award : show line 1 in the form Employee Stock Option (right to buy) | +1,024,152 | 1,024,152 | D |
Loading xslF345X06/form4-09282026_040901.xml…